Contact

All Stories

  1. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease

    Article • Stem Cell Research & Therapy, July 2024, Springer Science + Business Media

    Dr Theodora Katsila

  2. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins

    Article • International Journal of Molecular Sciences, May 2024, MDPI AG

    Dr Theodora Katsila

  3. Clinical implementation of preemptive pharmacogenomics in psychiatry

    Article • EBioMedicine, March 2024, Elsevier

    Dr Theodora Katsila

  4. Data-Driven Drug Repurposing in Diabetes Mellitus through an Enhanced Knowledge Graph

    Article • October 2023, MDPI AG

    Dr Theodora Katsila

  5. Cloudscreen: A “one-stop-shop” Platform for Drug Repurposing

    Article • September 2023, ScienceOpen

    Dr Theodora Katsila

  6. A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives

    Article • Frontiers in Molecular Neuroscience, September 2023, Frontiers

    Dr Theodora Katsila

  7. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing

    Article • OMICS A Journal of Integrative Biology, July 2023, Mary Ann Liebert Inc

    Dr Theodora Katsila

  8. Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes

    Article • Metabolites, February 2023, MDPI AG

    Dr Theodora Katsila

  9. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    Article • The Lancet, February 2023, Elsevier

    Dr Theodora Katsila

  10. Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery

    Article • Pharmaceutics, January 2023, MDPI AG

    Dr Theodora Katsila

  11. CAR Exosome-Based Therapeutics

    Article • January 2023, Springer Science + Business Media

    Dr Theodora Katsila

  12. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean

    Article • OMICS A Journal of Integrative Biology, October 2022, Mary Ann Liebert Inc

    Dr Theodora Katsila

  13. Untargeted Metabolomics for Disease-Specific Signatures

    Article • September 2022, Springer Science + Business Media

    Dr Theodora Katsila

  14. Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications

    Article • Anticancer Research, July 2022, International Institute of Anticancer Research

    Dr Theodora Katsila

  15. Diagnostic and Therapeutic Challenges in a Patient with Ureteral Metastases from a Triple Negative Breast Cancer

    Article • July 2022, MDPI AG

    Dr Theodora Katsila

  16. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes

    Article • June 2022, MDPI AG

    Dr Theodora Katsila

  17. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review

    Article • Human Genetics, April 2022, Springer Science + Business Media

    Dr Theodora Katsila

  18. ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses

    Article • Biomolecules, March 2022, MDPI AG

    Dr Theodora Katsila

  19. Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity

    Article • Biomedicines, March 2022, MDPI AG

    Dr Theodora Katsila

  20. Three-Dimensional Cell Metabolomics Deciphers the Anti-Angiogenic Properties of the Radioprotectant Amifostine

    Article • Cancers, June 2021, MDPI AG

    Dr Theodora Katsila

  21. Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Dr Theodora Katsila, Dr VERONIKI VIDALI

  22. Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts

    Article • Cancers, November 2020, MDPI AG

    Dr Theodora Katsila

  23. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe “PREPARE” study

    Article • Psychiatriki, October 2020, Hellenic Psychiatric Association

    Maria Skokou, Dr Theodora Katsila

  24. The role of microRNAs in gliomas – Therapeutic implications

    Article • Current Molecular Pharmacology, July 2020, Bentham Science Publishers

    Dr Theodora Katsila

  25. VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    Dr Theodora Katsila

  26. Pharmacomicrobiomics informs clinical pharmacogenomics

    Article • Pharmacogenomics, July 2019, Future Medicine

    Dr Theodora Katsila

  27. A Noninvasive Ocular (Tear) Sampling Method for Genetic Ascertainment of Transgenic Mice and Research Ethics Innovation

    Article • OMICS A Journal of Integrative Biology, June 2019, Mary Ann Liebert Inc

    Dr Theodora Katsila

  28. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis

    Article • Human Mutation, January 2019, Wiley

    Dr Theodora Katsila

  29. Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention

    Article • The Pharmacogenomics Journal, January 2019, Springer Science + Business Media

    Dr Theodora Katsila

  30. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study

    Article • Hemoglobin, January 2019, Taylor & Francis

    Dr Theodora Katsila, George Patrinos, Bassam Ali

  31. Implementation of Genomic Medicine

    Article • January 2019, Elsevier

    Dr Theodora Katsila

  32. How far have we come with contextual data integration in drug discovery?

    Article • Expert Opinion on Drug Discovery, July 2018, Taylor & Francis

    Minos Matsoukas, Dr Theodora Katsila

  33. Variants in TPMT, ITPA, ABCC4 And ABCB1 Genes as Predictors of 6-Mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia

    Article • July 2018, De Gruyter

    Dr Theodora Katsila

  34. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients

    Article • Anticancer Research, March 2018, International Institute of Anticancer Research

    Dr Theodora Katsila

  35. The New Age of -omics in Urothelial Cancer – Re-wording Its Diagnosis and Treatment

    Article • EBioMedicine, February 2018, Elsevier

    Dr Theodora Katsila

  36. Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment

    Article • Pharmacogenomics, January 2018, Future Medicine

    Dr Theodora Katsila

  37. Searching for Clinically Relevant Biomarkers in Geriatric Oncology

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Dr Theodora Katsila, George Patrinos

  38. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis

    Article • OMICS A Journal of Integrative Biology, January 2018, Mary Ann Liebert Inc

    Dr Theodora Katsila

  39. Proteomics and Metabolomics Data Analysis for Translational Medicine

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  40. A Review of Tools to Automatically Infer Chromosomal Positions From dbSNP and HGVS Genetic Variants

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  41. Economic Evaluation and Cost-Effectiveness Analysis of Genomic Medicine Interventions in Developing and Emerging Countries

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  42. Human Genomic Databases in Translational Medicine

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  43. Translating Genomic Information to Rationalize Drug Use

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  44. Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia

    Article • OMICS A Journal of Integrative Biology, December 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  45. Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients

    Article • Human Genomics, December 2017, Springer Science + Business Media

    Dr Theodora Katsila

  46. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” Strategy

    Article • OMICS A Journal of Integrative Biology, November 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  47. Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients

    Article • Human Genomics, October 2017, Springer Science + Business Media

    Dr Theodora Katsila

  48. Cancer Genomics and Public Health

    Article • September 2017, Karger Publishers

    Dr Theodora Katsila

  49. Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping

    Article • The American Journal of Human Genetics, September 2017, Elsevier

    Dr Theodora Katsila

  50. Exploring public genomics data for population pharmacogenomics

    Article • PLoS ONE, August 2017, PLOS

    Dr Theodora Katsila

  51. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation

    Article • OMICS A Journal of Integrative Biology, August 2017, Mary Ann Liebert Inc

    Minos Matsoukas, Dr Theodora Katsila

  52. Key Pharmacogenomic Considerations for Sickle Cell Disease Patients

    Article • OMICS A Journal of Integrative Biology, June 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  53. Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment

    Article • Current Pharmaceutical Design, May 2017, Bentham Science Publishers

    Dr Theodora Katsila

  54. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

    Article • PLoS ONE, February 2017, PLOS

    Dr Theodora Katsila

  55. Genomic Medicine in Developing Countries and Resource-Limited Environments

    Article • January 2017, Elsevier

    Professor Diego A Forero, Dr Theodora Katsila

  56. Genomic Databases

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  57. Perspectives for Future DNA Sequencing Techniques and Applications

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  58. Cancer Genomics and Public Health

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  59. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  60. Exosomes: A Cancer Theranostics Road Map

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  61. Pharmacogenomics in Clinical Care and Drug Discovery

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  62. Low- and Medium-Throughput Variant Detection Methods

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  63. Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece

    Article • Pharmacogenomics, November 2016, Future Medicine

    Dr Theodora Katsila

  64. Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy

    Article • Pharmacogenomics, November 2016, Future Medicine

    Dr Theodora Katsila

  65. Pharmacometabolomics Informs Viromics toward Precision Medicine

    Article • Frontiers in Pharmacology, October 2016, Frontiers

    Dr Theodora Katsila

  66. Novel genetic risk variants for pediatric celiac disease

    Article • Human Genomics, October 2016, Springer Science + Business Media

    Dr Theodora Katsila

  67. Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies

    Article • Nucleic Acids Research, October 2016, Oxford University Press (OUP)

    Dr Theodora Katsila

  68. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

    Article • PLoS ONE, September 2016, PLOS

    Dr Theodora Katsila

  69. ePGA: A Web-Based Information System for Translational Pharmacogenomics

    Article • PLoS ONE, September 2016, PLOS

    Dr Theodora Katsila

  70. Development and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma

    Article • Biomedical Chromatography, March 2016, Wiley

    Dr Theodora Katsila

  71. Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease

    Article • EBioMedicine, March 2016, Elsevier

    Dr Theodora Katsila

  72. Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients

    Article • Pharmacogenomics, March 2016, Future Medicine

    Dr Theodora Katsila

  73. Nutrigenomics 2.0: The Need for Ongoing andIndependentEvaluation and Synthesis of Commercial Nutrigenomics Tests' Scientific Knowledge Base for Responsible Innovation

    Article • OMICS A Journal of Integrative Biology, February 2016, Mary Ann Liebert Inc

    Dr Theodora Katsila, Prof. Jean-Christophe Nebel

  74. Allele and genotype frequencies of the two single nucleotide polymorphisms in the VKORC1 gene that are most important for warfarin treatment among Emiratis

    Article • Hamdan Medical Journal, January 2016, Medknow

    Dr Theodora Katsila

  75. Computational approaches in target identification and drug discovery

    Article • Computational and Structural Biotechnology Journal, January 2016, Elsevier

    Dr Theodora Katsila, Minos Matsoukas

  76. Pharmacometabolomics: Applications and Challenges

    Article • Current Pharmacogenomics and Personalized Medicine, December 2015, Bentham Science Publishers

    Dr Theodora Katsila

  77. Functional Analysis of anAγ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress

    Article • Hemoglobin, November 2015, Taylor & Francis

    Dr Theodora Katsila

  78. Enabling pharmacogenomic services: Informatics and computational discovery aspects

    Article • November 2015, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Theodora Katsila

  79. Identification of a novel homozygous SPG7 mutation by whole exome sequencing in a Greek family with a complicated form of hereditary spastic paraplegia

    Article • European Journal of Medical Genetics, November 2015, Elsevier

    Dr Theodora Katsila

  80. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner

    Article • Pharmacogenomics, October 2015, Future Medicine

    Dr Theodora Katsila

  81. Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics

    Article • Annual Review of Genomics and Human Genetics, September 2015, Annual Reviews

    Dr Theodora Katsila

  82. As solid scientific evidence is lacking, available nutrigenomics tests cannot be recommended

    Article • OMICS A Journal of Integrative Biology, September 2015, Mary Ann Liebert Inc

    Prof. Jean-Christophe Nebel, Dr Theodora Katsila

  83. The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

    Article • Frontiers in Pediatrics, July 2015, Frontiers

    Dr Theodora Katsila

  84. Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach

    Article • Human Genomics, June 2015, Springer Science + Business Media

    Dr Theodora Katsila

  85. Whole genome sequencing in pharmacogenomics

    Article • Frontiers in Pharmacology, March 2015, Frontiers

    Dr Theodora Katsila

  86. Nutrigenomics: A controversy

    Article • Applied & Translational Genomics, March 2015, Elsevier

    Dr Theodora Katsila

  87. Pharmacogenomics for Haemoglobinopathies Therapeutics

    Article • January 2015, Springer Science + Business Media

    Dr Theodora Katsila

  88. Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer

    Article • Clinical Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Dr Theodora Katsila

  89. Deciphering next-generation pharmacogenomics: an information technology perspective

    Article • Open Biology, July 2014, Royal Society Publishing

    Dr Theodora Katsila, George Patrinos

  90. Enhancing the Biological Relevance of Secretome-Based Proteomics by Linking Tumor Cell Proliferation and Protein Secretion

    Article • Journal of Proteome Research, July 2014, American Chemical Society (ACS)

    Dr Theodora Katsila

  91. Personalized pharmacogenomics profiling using whole-genome sequencing

    Article • Pharmacogenomics, July 2014, Future Medicine

    Dr Theodora Katsila

  92. Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients

    Article • Pharmacogenomics, July 2014, Future Medicine

    Dr Theodora Katsila

  93. Assessment of the Pharmacogenomics Educational Environment in Southeast Europe

    Article • Public Health Genomics, January 2014, Karger Publishers

    Dr Theodora Katsila

  94. DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics

    Article • Public Health Genomics, January 2014, Karger Publishers

    Dr Theodora Katsila

  95. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice

    Article • European Journal of Cancer, May 2013, Elsevier

    Dr Theodora Katsila

  96. Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: Enhanced enzymatic stability and biological properties

    Article • European Journal of Medicinal Chemistry, December 2012, Elsevier

    Dr Theodora Katsila

  97. 1077 Ovarian Malignant Ascites-derived Lymphocytes Stimulated With Prothymosin Alpha or Its Immunoactive Decapeptide Lyse Autologous Tumor Cells in Vitro and Retard Tumor Growth in SCID Mice

    Article • European Journal of Cancer, July 2012, Elsevier

    Dr Theodora Katsila

  98. Peptide and protein drugs: The study of their metabolism and catabolism by mass spectrometry

    Article • Mass Spectrometry Reviews, June 2011, Wiley

    Dr Theodora Katsila

  99. Evaluation of a Stable Gonadotropin-Releasing Hormone Analog in Mice for the Treatment of Endocrine Disorders and Prostate Cancer

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Theodora Katsila

  100. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Dr Theodora Katsila

  101. Simultaneous Absolute Quantification of the Glucose-Dependent Insulinotropic Polypeptides GIP1−42and GIP3−42in Mouse Plasma by LC/ESI-MS/MS: Preclinical Evaluation of DP-IV Inhibitors

    Article • Journal of Proteome Research, July 2009, American Chemical Society (ACS)

    Dr Theodora Katsila

  102. In vivoevaluation andin vitrometabolism of leuprolide in mice-mass spectrometry-based biomarker measurement for efficacy and toxicity

    Article • Journal of Mass Spectrometry, October 2008, Wiley

    Dr Theodora Katsila

  103. Evaluation of gonadotropin-releasing hormone analogues in mice – pharmacokinetic studies and biomarker based efficacy by mass spetrometry

    Article • European Journal of Cancer Supplements, July 2008, Elsevier

    Dr Theodora Katsila